MedTrace Logo

Factors Associated With Hyponatremia Induced by High-dose Cyclophosphamide

NCT02399358 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2015-12-17

No results posted yet for this study

Summary

Prospoctive cohort of high-dose cyclophosphamide exposed patients. With active estandardize screening of hyponatremia development in the follow up period.

Conditions

Sponsors & Collaborators

  • Diego Hernan Giunta, MD

    lead OTHER

Principal Investigators

  • Fernando Warley, MD · Hospital Italiano de Buenos Aires

  • Belen Bonella, MD · Hospital Italiano de Buenos Aires

  • Victoria Otero, MD · Hospital Italiano de Buenos Aires

  • Bruno L Ferreyro, MD · Hospital Italiano de Buenos Aires

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2017-06-30
Completion
2017-11-30

Countries

  • Argentina

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02399358 on ClinicalTrials.gov